Osaic Holdings’s AbbVie ABBV Stock Holding History

Osaic Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1	Closed	-$5.2K	–	7819
2025 Q3	$5.2K	Hold	1	–	–	﹤0.01%	6726
2025 Q2	$3.08K	Hold	1	–	–	﹤0.01%	6783
2025 Q1	$5.29K	Hold	1	–	–	﹤0.01%	6147
2024 Q4	$2.65K	Buy	+1	New	+$184	﹤0.01%	6493

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Osaic Holdings's ABBV Position: Q2 2026 in Review

Osaic Holdings increased its AbbVie (ABBV) stake by 18% in Q2 2026, buying an estimated $27.7M and bringing the position to 855,570 shares worth $215M. The position accounts for 0.25% of the portfolio, ranked #70.

Osaic Holdings first reported a position in ABBV in Q1 2020 and has held it in 26 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Osaic Holdings held 855,570 shares of AbbVie worth $215M as of Q2 2026.
Osaic Holdings bought 128,649 AbbVie shares in Q2 2026, an estimated $27.7M.
AbbVie made up 0.25% of Osaic Holdings's portfolio in Q2 2026, its #70 holding.
Osaic Holdings first reported a position in AbbVie in Q1 2020 and has held it in 26 quarters since.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.